IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $38,501,000 | +24.3% | 1,979,464 | +6.4% | 0.65% | +22.9% |
Q4 2017 | $30,968,000 | +103.0% | 1,859,924 | +147.5% | 0.53% | +108.3% |
Q3 2017 | $15,257,000 | +25.5% | 751,576 | -0.4% | 0.25% | +21.0% |
Q2 2017 | $12,153,000 | +23.6% | 754,865 | -2.9% | 0.21% | +13.5% |
Q1 2017 | $9,830,000 | -1.6% | 777,095 | +3.1% | 0.18% | -4.6% |
Q4 2016 | $9,990,000 | -53.2% | 753,953 | -16.3% | 0.19% | -51.6% |
Q3 2016 | $21,340,000 | -19.3% | 900,433 | -1.8% | 0.40% | -26.6% |
Q2 2016 | $26,437,000 | +6.7% | 917,323 | +18.5% | 0.55% | -0.5% |
Q1 2016 | $24,783,000 | +1179.5% | 773,973 | +1608.7% | 0.55% | +1120.0% |
Q4 2015 | $1,937,000 | +25.2% | 45,295 | +3.1% | 0.04% | +21.6% |
Q3 2015 | $1,547,000 | +0.8% | 43,945 | +31.5% | 0.04% | +5.7% |
Q2 2015 | $1,535,000 | -4.0% | 33,420 | -2.0% | 0.04% | -2.8% |
Q1 2015 | $1,599,000 | – | 34,115 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |